PMC:7319613 / 5972-6236 JSONTXT

{"project":"LitCovid-PMC-OGER-BB","denotations":[{"id":"T104","span":{"begin":65,"end":69},"obj":"G_3;PG_10;PR:000003622"},{"id":"T105","span":{"begin":150,"end":154},"obj":"CHEBI:23888;CHEBI:23888"},{"id":"T106","span":{"begin":189,"end":199},"obj":"CHEBI:35222;CHEBI:35222"},{"id":"T107","span":{"begin":207,"end":221},"obj":"DG_37"},{"id":"T108","span":{"begin":259,"end":263},"obj":"G_3;PG_10;PR:000003622"},{"id":"T86139","span":{"begin":65,"end":69},"obj":"G_3;PG_10;PR:000003622"},{"id":"T70794","span":{"begin":150,"end":154},"obj":"CHEBI:23888;CHEBI:23888"},{"id":"T66606","span":{"begin":189,"end":199},"obj":"CHEBI:35222;CHEBI:35222"},{"id":"T7504","span":{"begin":207,"end":221},"obj":"DG_37"},{"id":"T88363","span":{"begin":259,"end":263},"obj":"G_3;PG_10;PR:000003622"}],"text":"One also has to bear in mind that the prematurity-related higher ACE2 activity might be additionally heightened by potential hypertension or diabetes drug therapies which often include ACE inhibitors and/or angiotensin II receptor blockers, both upregulating ACE2."}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T30","span":{"begin":125,"end":137},"obj":"Disease"},{"id":"T31","span":{"begin":141,"end":149},"obj":"Disease"}],"attributes":[{"id":"A30","pred":"mondo_id","subj":"T30","obj":"http://purl.obolibrary.org/obo/MONDO_0005044"},{"id":"A31","pred":"mondo_id","subj":"T31","obj":"http://purl.obolibrary.org/obo/MONDO_0005015"}],"text":"One also has to bear in mind that the prematurity-related higher ACE2 activity might be additionally heightened by potential hypertension or diabetes drug therapies which often include ACE inhibitors and/or angiotensin II receptor blockers, both upregulating ACE2."}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T30","span":{"begin":9,"end":12},"obj":"http://purl.obolibrary.org/obo/CLO_0051582"},{"id":"T31","span":{"begin":70,"end":78},"obj":"http://purl.obolibrary.org/obo/CLO_0001658"}],"text":"One also has to bear in mind that the prematurity-related higher ACE2 activity might be additionally heightened by potential hypertension or diabetes drug therapies which often include ACE inhibitors and/or angiotensin II receptor blockers, both upregulating ACE2."}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T9","span":{"begin":150,"end":154},"obj":"Chemical"},{"id":"T10","span":{"begin":185,"end":199},"obj":"Chemical"},{"id":"T11","span":{"begin":189,"end":199},"obj":"Chemical"},{"id":"T12","span":{"begin":207,"end":221},"obj":"Chemical"},{"id":"T15","span":{"begin":207,"end":218},"obj":"Chemical"},{"id":"T16","span":{"begin":219,"end":221},"obj":"Chemical"}],"attributes":[{"id":"A9","pred":"chebi_id","subj":"T9","obj":"http://purl.obolibrary.org/obo/CHEBI_23888"},{"id":"A10","pred":"chebi_id","subj":"T10","obj":"http://purl.obolibrary.org/obo/CHEBI_35457"},{"id":"A11","pred":"chebi_id","subj":"T11","obj":"http://purl.obolibrary.org/obo/CHEBI_35222"},{"id":"A12","pred":"chebi_id","subj":"T12","obj":"http://purl.obolibrary.org/obo/CHEBI_2719"},{"id":"A13","pred":"chebi_id","subj":"T12","obj":"http://purl.obolibrary.org/obo/CHEBI_48432"},{"id":"A14","pred":"chebi_id","subj":"T12","obj":"http://purl.obolibrary.org/obo/CHEBI_58506"},{"id":"A15","pred":"chebi_id","subj":"T15","obj":"http://purl.obolibrary.org/obo/CHEBI_48433"},{"id":"A16","pred":"chebi_id","subj":"T16","obj":"http://purl.obolibrary.org/obo/CHEBI_74067"}],"text":"One also has to bear in mind that the prematurity-related higher ACE2 activity might be additionally heightened by potential hypertension or diabetes drug therapies which often include ACE inhibitors and/or angiotensin II receptor blockers, both upregulating ACE2."}

{"project":"LitCovid-PubTator","denotations":[{"id":"124","span":{"begin":65,"end":69},"obj":"Gene"},{"id":"125","span":{"begin":185,"end":188},"obj":"Gene"},{"id":"126","span":{"begin":259,"end":263},"obj":"Gene"},{"id":"132","span":{"begin":125,"end":137},"obj":"Disease"},{"id":"133","span":{"begin":141,"end":149},"obj":"Disease"}],"attributes":[{"id":"A124","pred":"tao:has_database_id","subj":"124","obj":"Gene:59272"},{"id":"A125","pred":"tao:has_database_id","subj":"125","obj":"Gene:1636"},{"id":"A126","pred":"tao:has_database_id","subj":"126","obj":"Gene:59272"},{"id":"A132","pred":"tao:has_database_id","subj":"132","obj":"MESH:D006973"},{"id":"A133","pred":"tao:has_database_id","subj":"133","obj":"MESH:D003920"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"One also has to bear in mind that the prematurity-related higher ACE2 activity might be additionally heightened by potential hypertension or diabetes drug therapies which often include ACE inhibitors and/or angiotensin II receptor blockers, both upregulating ACE2."}

{"project":"LitCovid-PD-HP","denotations":[{"id":"T22","span":{"begin":125,"end":137},"obj":"Phenotype"}],"attributes":[{"id":"A22","pred":"hp_id","subj":"T22","obj":"http://purl.obolibrary.org/obo/HP_0000822"}],"text":"One also has to bear in mind that the prematurity-related higher ACE2 activity might be additionally heightened by potential hypertension or diabetes drug therapies which often include ACE inhibitors and/or angiotensin II receptor blockers, both upregulating ACE2."}

{"project":"LitCovid-sentences","denotations":[{"id":"T37","span":{"begin":0,"end":264},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"One also has to bear in mind that the prematurity-related higher ACE2 activity might be additionally heightened by potential hypertension or diabetes drug therapies which often include ACE inhibitors and/or angiotensin II receptor blockers, both upregulating ACE2."}